Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study

A series of heteroleptic Ag(I) complexes bearing 4,6-dimethyl-2-pyrimidinethiol (dmp2SH), i.e., [AgCl(dmp2SH)(PPh3)2] (1), [Ag(dmp2SH)(PPh3)2]NO3 (2), [Ag(dmp2SΗ)(xantphos)]NO3 (3), [Ag(μ-dmp2S)(PPh3)]2 (4), [Ag(dmp2S)(xantphos)] (5), [Ag(μ-dmp2S)(DPEphos)]2 (6) (xantphos = 4,5-bis(diphenylphosphino...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inorganic biochemistry 2022-03, Vol.228, p.111695-111695, Article 111695
Hauptverfasser: Varna, Despoina, Geromichalou, Elena, Papachristou, Eleni, Papi, Rigini, Hatzidimitriou, Antonios G., Panteris, Emmanuel, Psomas, George, Geromichalos, George D., Aslanidis, Paraskevas, Choli-Papadopoulou, Theodora, Angaridis, Panagiotis A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111695
container_issue
container_start_page 111695
container_title Journal of inorganic biochemistry
container_volume 228
creator Varna, Despoina
Geromichalou, Elena
Papachristou, Eleni
Papi, Rigini
Hatzidimitriou, Antonios G.
Panteris, Emmanuel
Psomas, George
Geromichalos, George D.
Aslanidis, Paraskevas
Choli-Papadopoulou, Theodora
Angaridis, Panagiotis A.
description A series of heteroleptic Ag(I) complexes bearing 4,6-dimethyl-2-pyrimidinethiol (dmp2SH), i.e., [AgCl(dmp2SH)(PPh3)2] (1), [Ag(dmp2SH)(PPh3)2]NO3 (2), [Ag(dmp2SΗ)(xantphos)]NO3 (3), [Ag(μ-dmp2S)(PPh3)]2 (4), [Ag(dmp2S)(xantphos)] (5), [Ag(μ-dmp2S)(DPEphos)]2 (6) (xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and DPEPhos = bis[(2-diphenylphosphino)phenyl]ether) were synthesized. The complexes display systematic variation of particular structural characteristics which were proved to have a significant impact on their in vitro cytotoxicity and antimicrobial properties. A moderate-to-high potential for bacteria growth inhibition was observed for all complexes, with 2, 3 and 5 being particularly effective against Gram-(+) bacteria (IC50 = 1.6–4.5 μM). The three complexes exhibit high in vitro cytotoxicity against HeLa and MCF-7 cancer cells (IC50 = 0.32–3.00 μΜ), suggesting the importance of coordination unsaturation and cationic charge for effective bioactivity. A very low cytotoxicity against HDFa normal cells was observed, revealing a high degree of selectivity (selectivity index ~10) and, hence, biocompatibility. Fluorescence microscopy using 2 showed effective targeting on the membrane of the HeLa cancer cells, subsequently inducing cell death. Binding of the complexes to serum albumin proteins is reasonably strong for potential uptake and subsequent release to target sites. A moderate in vitro antioxidant capacity for free radicals scavenging was observed and a low potential to destroy the double-strand structure of calf-thymus DNA by intercalation, suggesting likely implication of these properties in the bioactivity mechanisms of these complexes. Further insight into possible mechanisms of bioactivity was obtained by molecular modeling calculations, by exploring their ability to act as potential inhibitors of DNA-gyrase, human estrogen receptor alpha, human cyclin-dependent kinase 6, and human papillomavirus E6 oncoprotein. A series of Ag(I) compounds bearing a heterocyclic thioamide and phosphine ligands were synthesized. Cationic and coordinatively unsaturated compounds exhibit high in vitro antimicrobial potency as well as high and selective to healthy cells in vitro cytotoxicity. In silico investigations shed light on their possible mechanisms of action. [Display omitted] •Ag(I) coordination compounds; heterocyclic thioamides and phosphine ligands•High in vitro antimicrobial potency•High in vitro cytotoxicity; HeLa and MCF-7 cancer cells
doi_str_mv 10.1016/j.jinorgbio.2021.111695
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618906715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0162013421003421</els_id><sourcerecordid>2618906715</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-a4e1e449d225594fe39362ffa83625c2a3fa3f5f094bd910ecc1b2bc3c0412da3</originalsourceid><addsrcrecordid>eNqFUcuOEzEQtBCIDQu_AD4uhwl-zUzmGFY8VlqJC5wtj92TdPCMg-1kyY1_4GP4H74ED1n2imSp7VZVl6uLkFecLTnjzZvdcodTiJsew1IwwZec86arH5EFX7WyklKpx2RRkKJiXKoL8iylHWOsrlX7lFzImrG2a-SC_HqLwYZxbzL2HmhCf4R4dfOazk0P3yHRO8xbuoUMMdiT9Whp3mIwIzqgHjdmcokOIdIEHmzGI9Cv6D1OGxoGas1kIVIL3idaoHSLm225ZBzRxtCj8dTMLMwn-vvHT7qelXucwFGcaGnH8JdXHuVzaANN-eBOz8mTwfgEL-7rJfny_t3n64_V7acPN9fr28rKlufKKOCgVOeEqOtODSA72YhhMKtSaiuMHMqpB9ap3nWcgbW8F72VlikunJGX5Oo8dx_DtwOkrEdMsxszQTgkLRq-6ljT8rpA2zO0-EopwqD3EUcTT5ozPaemd_ohNT2nps-pFebLe5FDP4J74P2LqQDWZwAUq0eEqJNFKJt1GMvOtQv4X5E_G9uySQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618906715</pqid></control><display><type>article</type><title>Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Varna, Despoina ; Geromichalou, Elena ; Papachristou, Eleni ; Papi, Rigini ; Hatzidimitriou, Antonios G. ; Panteris, Emmanuel ; Psomas, George ; Geromichalos, George D. ; Aslanidis, Paraskevas ; Choli-Papadopoulou, Theodora ; Angaridis, Panagiotis A.</creator><creatorcontrib>Varna, Despoina ; Geromichalou, Elena ; Papachristou, Eleni ; Papi, Rigini ; Hatzidimitriou, Antonios G. ; Panteris, Emmanuel ; Psomas, George ; Geromichalos, George D. ; Aslanidis, Paraskevas ; Choli-Papadopoulou, Theodora ; Angaridis, Panagiotis A.</creatorcontrib><description>A series of heteroleptic Ag(I) complexes bearing 4,6-dimethyl-2-pyrimidinethiol (dmp2SH), i.e., [AgCl(dmp2SH)(PPh3)2] (1), [Ag(dmp2SH)(PPh3)2]NO3 (2), [Ag(dmp2SΗ)(xantphos)]NO3 (3), [Ag(μ-dmp2S)(PPh3)]2 (4), [Ag(dmp2S)(xantphos)] (5), [Ag(μ-dmp2S)(DPEphos)]2 (6) (xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and DPEPhos = bis[(2-diphenylphosphino)phenyl]ether) were synthesized. The complexes display systematic variation of particular structural characteristics which were proved to have a significant impact on their in vitro cytotoxicity and antimicrobial properties. A moderate-to-high potential for bacteria growth inhibition was observed for all complexes, with 2, 3 and 5 being particularly effective against Gram-(+) bacteria (IC50 = 1.6–4.5 μM). The three complexes exhibit high in vitro cytotoxicity against HeLa and MCF-7 cancer cells (IC50 = 0.32–3.00 μΜ), suggesting the importance of coordination unsaturation and cationic charge for effective bioactivity. A very low cytotoxicity against HDFa normal cells was observed, revealing a high degree of selectivity (selectivity index ~10) and, hence, biocompatibility. Fluorescence microscopy using 2 showed effective targeting on the membrane of the HeLa cancer cells, subsequently inducing cell death. Binding of the complexes to serum albumin proteins is reasonably strong for potential uptake and subsequent release to target sites. A moderate in vitro antioxidant capacity for free radicals scavenging was observed and a low potential to destroy the double-strand structure of calf-thymus DNA by intercalation, suggesting likely implication of these properties in the bioactivity mechanisms of these complexes. Further insight into possible mechanisms of bioactivity was obtained by molecular modeling calculations, by exploring their ability to act as potential inhibitors of DNA-gyrase, human estrogen receptor alpha, human cyclin-dependent kinase 6, and human papillomavirus E6 oncoprotein. A series of Ag(I) compounds bearing a heterocyclic thioamide and phosphine ligands were synthesized. Cationic and coordinatively unsaturated compounds exhibit high in vitro antimicrobial potency as well as high and selective to healthy cells in vitro cytotoxicity. In silico investigations shed light on their possible mechanisms of action. [Display omitted] •Ag(I) coordination compounds; heterocyclic thioamides and phosphine ligands•High in vitro antimicrobial potency•High in vitro cytotoxicity; HeLa and MCF-7 cancer cells; selectivity to healthy cells•Interaction with DNA and serum albumins; antioxidant activity•Molecular docking; chemo-informatics analysis and drug-likeness</description><identifier>ISSN: 0162-0134</identifier><identifier>EISSN: 1873-3344</identifier><identifier>DOI: 10.1016/j.jinorgbio.2021.111695</identifier><identifier>PMID: 35007963</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Infective Agents - chemistry ; Anti-Infective Agents - pharmacology ; Antimicrobial activity ; Antineoplastic Agents - pharmacology ; Antioxidants - pharmacology ; Bacteria - drug effects ; Coordination Complexes - chemistry ; Crystal structures ; Cyclin-Dependent Kinase 6 - metabolism ; Cytotoxicity ; DNA - metabolism ; DNA Gyrase - metabolism ; HeLa Cells ; Heterocyclic thioamides ; Humans ; Ligands ; MCF-7 Cells ; Microbial Sensitivity Tests - methods ; Models, Molecular ; Molecular Docking Simulation - methods ; Phosphines - chemistry ; Selectivity ; Silver - chemistry ; Silver - pharmacology ; Silver(I) complexes ; Thioamides - chemistry ; Thioamides - pharmacology ; Xanthenes - chemistry</subject><ispartof>Journal of inorganic biochemistry, 2022-03, Vol.228, p.111695-111695, Article 111695</ispartof><rights>2021</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-a4e1e449d225594fe39362ffa83625c2a3fa3f5f094bd910ecc1b2bc3c0412da3</citedby><cites>FETCH-LOGICAL-c371t-a4e1e449d225594fe39362ffa83625c2a3fa3f5f094bd910ecc1b2bc3c0412da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jinorgbio.2021.111695$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35007963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varna, Despoina</creatorcontrib><creatorcontrib>Geromichalou, Elena</creatorcontrib><creatorcontrib>Papachristou, Eleni</creatorcontrib><creatorcontrib>Papi, Rigini</creatorcontrib><creatorcontrib>Hatzidimitriou, Antonios G.</creatorcontrib><creatorcontrib>Panteris, Emmanuel</creatorcontrib><creatorcontrib>Psomas, George</creatorcontrib><creatorcontrib>Geromichalos, George D.</creatorcontrib><creatorcontrib>Aslanidis, Paraskevas</creatorcontrib><creatorcontrib>Choli-Papadopoulou, Theodora</creatorcontrib><creatorcontrib>Angaridis, Panagiotis A.</creatorcontrib><title>Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study</title><title>Journal of inorganic biochemistry</title><addtitle>J Inorg Biochem</addtitle><description>A series of heteroleptic Ag(I) complexes bearing 4,6-dimethyl-2-pyrimidinethiol (dmp2SH), i.e., [AgCl(dmp2SH)(PPh3)2] (1), [Ag(dmp2SH)(PPh3)2]NO3 (2), [Ag(dmp2SΗ)(xantphos)]NO3 (3), [Ag(μ-dmp2S)(PPh3)]2 (4), [Ag(dmp2S)(xantphos)] (5), [Ag(μ-dmp2S)(DPEphos)]2 (6) (xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and DPEPhos = bis[(2-diphenylphosphino)phenyl]ether) were synthesized. The complexes display systematic variation of particular structural characteristics which were proved to have a significant impact on their in vitro cytotoxicity and antimicrobial properties. A moderate-to-high potential for bacteria growth inhibition was observed for all complexes, with 2, 3 and 5 being particularly effective against Gram-(+) bacteria (IC50 = 1.6–4.5 μM). The three complexes exhibit high in vitro cytotoxicity against HeLa and MCF-7 cancer cells (IC50 = 0.32–3.00 μΜ), suggesting the importance of coordination unsaturation and cationic charge for effective bioactivity. A very low cytotoxicity against HDFa normal cells was observed, revealing a high degree of selectivity (selectivity index ~10) and, hence, biocompatibility. Fluorescence microscopy using 2 showed effective targeting on the membrane of the HeLa cancer cells, subsequently inducing cell death. Binding of the complexes to serum albumin proteins is reasonably strong for potential uptake and subsequent release to target sites. A moderate in vitro antioxidant capacity for free radicals scavenging was observed and a low potential to destroy the double-strand structure of calf-thymus DNA by intercalation, suggesting likely implication of these properties in the bioactivity mechanisms of these complexes. Further insight into possible mechanisms of bioactivity was obtained by molecular modeling calculations, by exploring their ability to act as potential inhibitors of DNA-gyrase, human estrogen receptor alpha, human cyclin-dependent kinase 6, and human papillomavirus E6 oncoprotein. A series of Ag(I) compounds bearing a heterocyclic thioamide and phosphine ligands were synthesized. Cationic and coordinatively unsaturated compounds exhibit high in vitro antimicrobial potency as well as high and selective to healthy cells in vitro cytotoxicity. In silico investigations shed light on their possible mechanisms of action. [Display omitted] •Ag(I) coordination compounds; heterocyclic thioamides and phosphine ligands•High in vitro antimicrobial potency•High in vitro cytotoxicity; HeLa and MCF-7 cancer cells; selectivity to healthy cells•Interaction with DNA and serum albumins; antioxidant activity•Molecular docking; chemo-informatics analysis and drug-likeness</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Infective Agents - chemistry</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antimicrobial activity</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antioxidants - pharmacology</subject><subject>Bacteria - drug effects</subject><subject>Coordination Complexes - chemistry</subject><subject>Crystal structures</subject><subject>Cyclin-Dependent Kinase 6 - metabolism</subject><subject>Cytotoxicity</subject><subject>DNA - metabolism</subject><subject>DNA Gyrase - metabolism</subject><subject>HeLa Cells</subject><subject>Heterocyclic thioamides</subject><subject>Humans</subject><subject>Ligands</subject><subject>MCF-7 Cells</subject><subject>Microbial Sensitivity Tests - methods</subject><subject>Models, Molecular</subject><subject>Molecular Docking Simulation - methods</subject><subject>Phosphines - chemistry</subject><subject>Selectivity</subject><subject>Silver - chemistry</subject><subject>Silver - pharmacology</subject><subject>Silver(I) complexes</subject><subject>Thioamides - chemistry</subject><subject>Thioamides - pharmacology</subject><subject>Xanthenes - chemistry</subject><issn>0162-0134</issn><issn>1873-3344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcuOEzEQtBCIDQu_AD4uhwl-zUzmGFY8VlqJC5wtj92TdPCMg-1kyY1_4GP4H74ED1n2imSp7VZVl6uLkFecLTnjzZvdcodTiJsew1IwwZec86arH5EFX7WyklKpx2RRkKJiXKoL8iylHWOsrlX7lFzImrG2a-SC_HqLwYZxbzL2HmhCf4R4dfOazk0P3yHRO8xbuoUMMdiT9Whp3mIwIzqgHjdmcokOIdIEHmzGI9Cv6D1OGxoGas1kIVIL3idaoHSLm225ZBzRxtCj8dTMLMwn-vvHT7qelXucwFGcaGnH8JdXHuVzaANN-eBOz8mTwfgEL-7rJfny_t3n64_V7acPN9fr28rKlufKKOCgVOeEqOtODSA72YhhMKtSaiuMHMqpB9ap3nWcgbW8F72VlikunJGX5Oo8dx_DtwOkrEdMsxszQTgkLRq-6ljT8rpA2zO0-EopwqD3EUcTT5ozPaemd_ohNT2nps-pFebLe5FDP4J74P2LqQDWZwAUq0eEqJNFKJt1GMvOtQv4X5E_G9uySQ</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Varna, Despoina</creator><creator>Geromichalou, Elena</creator><creator>Papachristou, Eleni</creator><creator>Papi, Rigini</creator><creator>Hatzidimitriou, Antonios G.</creator><creator>Panteris, Emmanuel</creator><creator>Psomas, George</creator><creator>Geromichalos, George D.</creator><creator>Aslanidis, Paraskevas</creator><creator>Choli-Papadopoulou, Theodora</creator><creator>Angaridis, Panagiotis A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study</title><author>Varna, Despoina ; Geromichalou, Elena ; Papachristou, Eleni ; Papi, Rigini ; Hatzidimitriou, Antonios G. ; Panteris, Emmanuel ; Psomas, George ; Geromichalos, George D. ; Aslanidis, Paraskevas ; Choli-Papadopoulou, Theodora ; Angaridis, Panagiotis A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-a4e1e449d225594fe39362ffa83625c2a3fa3f5f094bd910ecc1b2bc3c0412da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Infective Agents - chemistry</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antimicrobial activity</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antioxidants - pharmacology</topic><topic>Bacteria - drug effects</topic><topic>Coordination Complexes - chemistry</topic><topic>Crystal structures</topic><topic>Cyclin-Dependent Kinase 6 - metabolism</topic><topic>Cytotoxicity</topic><topic>DNA - metabolism</topic><topic>DNA Gyrase - metabolism</topic><topic>HeLa Cells</topic><topic>Heterocyclic thioamides</topic><topic>Humans</topic><topic>Ligands</topic><topic>MCF-7 Cells</topic><topic>Microbial Sensitivity Tests - methods</topic><topic>Models, Molecular</topic><topic>Molecular Docking Simulation - methods</topic><topic>Phosphines - chemistry</topic><topic>Selectivity</topic><topic>Silver - chemistry</topic><topic>Silver - pharmacology</topic><topic>Silver(I) complexes</topic><topic>Thioamides - chemistry</topic><topic>Thioamides - pharmacology</topic><topic>Xanthenes - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varna, Despoina</creatorcontrib><creatorcontrib>Geromichalou, Elena</creatorcontrib><creatorcontrib>Papachristou, Eleni</creatorcontrib><creatorcontrib>Papi, Rigini</creatorcontrib><creatorcontrib>Hatzidimitriou, Antonios G.</creatorcontrib><creatorcontrib>Panteris, Emmanuel</creatorcontrib><creatorcontrib>Psomas, George</creatorcontrib><creatorcontrib>Geromichalos, George D.</creatorcontrib><creatorcontrib>Aslanidis, Paraskevas</creatorcontrib><creatorcontrib>Choli-Papadopoulou, Theodora</creatorcontrib><creatorcontrib>Angaridis, Panagiotis A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of inorganic biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varna, Despoina</au><au>Geromichalou, Elena</au><au>Papachristou, Eleni</au><au>Papi, Rigini</au><au>Hatzidimitriou, Antonios G.</au><au>Panteris, Emmanuel</au><au>Psomas, George</au><au>Geromichalos, George D.</au><au>Aslanidis, Paraskevas</au><au>Choli-Papadopoulou, Theodora</au><au>Angaridis, Panagiotis A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study</atitle><jtitle>Journal of inorganic biochemistry</jtitle><addtitle>J Inorg Biochem</addtitle><date>2022-03</date><risdate>2022</risdate><volume>228</volume><spage>111695</spage><epage>111695</epage><pages>111695-111695</pages><artnum>111695</artnum><issn>0162-0134</issn><eissn>1873-3344</eissn><abstract>A series of heteroleptic Ag(I) complexes bearing 4,6-dimethyl-2-pyrimidinethiol (dmp2SH), i.e., [AgCl(dmp2SH)(PPh3)2] (1), [Ag(dmp2SH)(PPh3)2]NO3 (2), [Ag(dmp2SΗ)(xantphos)]NO3 (3), [Ag(μ-dmp2S)(PPh3)]2 (4), [Ag(dmp2S)(xantphos)] (5), [Ag(μ-dmp2S)(DPEphos)]2 (6) (xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and DPEPhos = bis[(2-diphenylphosphino)phenyl]ether) were synthesized. The complexes display systematic variation of particular structural characteristics which were proved to have a significant impact on their in vitro cytotoxicity and antimicrobial properties. A moderate-to-high potential for bacteria growth inhibition was observed for all complexes, with 2, 3 and 5 being particularly effective against Gram-(+) bacteria (IC50 = 1.6–4.5 μM). The three complexes exhibit high in vitro cytotoxicity against HeLa and MCF-7 cancer cells (IC50 = 0.32–3.00 μΜ), suggesting the importance of coordination unsaturation and cationic charge for effective bioactivity. A very low cytotoxicity against HDFa normal cells was observed, revealing a high degree of selectivity (selectivity index ~10) and, hence, biocompatibility. Fluorescence microscopy using 2 showed effective targeting on the membrane of the HeLa cancer cells, subsequently inducing cell death. Binding of the complexes to serum albumin proteins is reasonably strong for potential uptake and subsequent release to target sites. A moderate in vitro antioxidant capacity for free radicals scavenging was observed and a low potential to destroy the double-strand structure of calf-thymus DNA by intercalation, suggesting likely implication of these properties in the bioactivity mechanisms of these complexes. Further insight into possible mechanisms of bioactivity was obtained by molecular modeling calculations, by exploring their ability to act as potential inhibitors of DNA-gyrase, human estrogen receptor alpha, human cyclin-dependent kinase 6, and human papillomavirus E6 oncoprotein. A series of Ag(I) compounds bearing a heterocyclic thioamide and phosphine ligands were synthesized. Cationic and coordinatively unsaturated compounds exhibit high in vitro antimicrobial potency as well as high and selective to healthy cells in vitro cytotoxicity. In silico investigations shed light on their possible mechanisms of action. [Display omitted] •Ag(I) coordination compounds; heterocyclic thioamides and phosphine ligands•High in vitro antimicrobial potency•High in vitro cytotoxicity; HeLa and MCF-7 cancer cells; selectivity to healthy cells•Interaction with DNA and serum albumins; antioxidant activity•Molecular docking; chemo-informatics analysis and drug-likeness</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35007963</pmid><doi>10.1016/j.jinorgbio.2021.111695</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0162-0134
ispartof Journal of inorganic biochemistry, 2022-03, Vol.228, p.111695-111695, Article 111695
issn 0162-0134
1873-3344
language eng
recordid cdi_proquest_miscellaneous_2618906715
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-Bacterial Agents - pharmacology
Anti-Infective Agents - chemistry
Anti-Infective Agents - pharmacology
Antimicrobial activity
Antineoplastic Agents - pharmacology
Antioxidants - pharmacology
Bacteria - drug effects
Coordination Complexes - chemistry
Crystal structures
Cyclin-Dependent Kinase 6 - metabolism
Cytotoxicity
DNA - metabolism
DNA Gyrase - metabolism
HeLa Cells
Heterocyclic thioamides
Humans
Ligands
MCF-7 Cells
Microbial Sensitivity Tests - methods
Models, Molecular
Molecular Docking Simulation - methods
Phosphines - chemistry
Selectivity
Silver - chemistry
Silver - pharmacology
Silver(I) complexes
Thioamides - chemistry
Thioamides - pharmacology
Xanthenes - chemistry
title Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A09%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biocompatible%20silver(I)%20complexes%20with%20heterocyclic%20thioamide%20ligands%20for%20selective%20killing%20of%20cancer%20cells%20and%20high%20antimicrobial%20activity%20%E2%80%93%20A%20combined%20in%20vitro%20and%20in%20silico%20study&rft.jtitle=Journal%20of%20inorganic%20biochemistry&rft.au=Varna,%20Despoina&rft.date=2022-03&rft.volume=228&rft.spage=111695&rft.epage=111695&rft.pages=111695-111695&rft.artnum=111695&rft.issn=0162-0134&rft.eissn=1873-3344&rft_id=info:doi/10.1016/j.jinorgbio.2021.111695&rft_dat=%3Cproquest_cross%3E2618906715%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618906715&rft_id=info:pmid/35007963&rft_els_id=S0162013421003421&rfr_iscdi=true